Latest News about IMVT
Recent news which mentions IMVT
   What's Going On Pfizer's Subsidiary Biohaven Stock?
   
  
  
  September 27, 2023
  From Benzinga
 
   Why Sharps Technology Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
   
  
  
  September 27, 2023
  From Benzinga
 
   Why Immunovant Stock Is Bolting Higher Today
   
  
  
  September 27, 2023
  From Motley Fool
 
   Benzinga's Top Ratings Upgrades, Downgrades For September 27, 2023
   
  
  
  September 27, 2023
  From Benzinga
 
   MillerKnoll, Hayward Holdings, Ginkgo Bioworks And Other Big Stocks Moving Higher On Wednesday
   
  
  
  September 27, 2023
  From Benzinga
 
   Why Shares of Immunovant Are Soaring on Tuesday
   
  
  
  September 26, 2023
  From Motley Fool
 
   Nasdaq Down 1.5%; Immunovant Shares Spike Higher
   
  
  
  September 26, 2023
  From Benzinga
 
   12 Health Care Stocks Moving In Tuesday's Intraday Session
   
  
  
  September 26, 2023
  From Benzinga
 
   Why TD SYNNEX Shares Are Trading Lower By Over 5%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
   
  
  
  September 26, 2023
  From Benzinga
 
   Crude Oil Moves Higher; Cintas Earnings Top Estimates
   
  
  
  September 26, 2023
  From Benzinga
 
   Fisker, Intercept Pharmaceuticals, Immunovant And Other Big Stocks Moving Higher On Tuesday
   
  
  
  September 26, 2023
  From Benzinga
 
   Why Is Autoimmune Disease-Focused Immunovant Stock Trading Higher Today?
   
  
  
  September 26, 2023
  From Benzinga
 
   These 2 Biotech Stocks Are Bucking a Down Market Tuesday
   
  
  
  September 26, 2023
  From Motley Fool
 
   12 Health Care Stocks Moving In Tuesday's Pre-Market Session
   
  
  
  September 26, 2023
  From Benzinga
 From InvestorPlace
 
   10 Health Care Stocks Whale Activity In Today's Session
   
  
  
  September 18, 2023
  From Benzinga
 
   If You Invested $1000 In Vivek Ramaswamy-Founded Roivant When He Declared Presidential Bid, Here's How Much You'd Have Now
   
  
  
  August 25, 2023
  From Benzinga
 
   Immunovant's FcRn Strategy Gains Momentum: Analysts View ADHERE Study as De-Risking Factor for CIDP Clinical Development
   
  
  
  July 18, 2023
  From Benzinga
 From InvestorPlace
 
   Activision Blizzard, Argenx And Other Big Stocks Moving Lower In Monday's Pre-Market Session
   
  
  
  July 17, 2023
  From Benzinga
 From Benzinga
 From Benzinga
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.
 
